BREYNA 160 ug/1

Breyna 160 µg/1 is a metered aerosol containing Budesonide and Formoterol Fumarate, designed for respiratory inhalation. This combination medication is commonly used for managing asthma and chronic obstructive pulmonary disease (COPD).

Breyna 160 µg/1 is primarily used for the maintenance treatment of asthma and chronic obstructive pulmonary disease (COPD). It combines Budesonide, a corticosteroid, and Formoterol Fumarate, a long-acting beta-agonist, to reduce inflammation and relax airway muscles. This medication is often prescribed to improve breathing and prevent symptoms such as wheezing and shortness of breath. Patients may wonder, 'What is Breyna 160 µg/1 used for?' It is typically used as a long-term control medication rather than for immediate relief of acute symptoms.

Common effects of Breyna 160 µg/1 may include throat irritation, hoarseness, and a dry mouth. Some users might experience headaches, tremors, or an increased heart rate. These effects are generally mild and temporary. If any severe or persistent effects occur, it is important to consult a healthcare provider.

Breyna 160 µg/1 should be used as directed by a healthcare professional. It is important to rinse your mouth after each use to reduce the risk of oral thrush. Patients with certain medical conditions, such as heart disease or diabetes, should discuss their use of this medication with their healthcare provider. Always store the aerosol canister upright and away from heat and flame.

Breyna 160 µg/1 may interact with other medications, including beta-blockers, diuretics, and certain antidepressants. It is advisable to inform your healthcare provider about all medications you are taking. Consuming alcohol while using this medication may increase the risk of side effects. Always consult a healthcare professional before starting any new medication.